These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29873834)

  • 1. Characterization of cyclic Cushing's disease using late night salivary cortisol testing.
    Jahandideh D; Swearingen B; Nachtigall LB; Klibanski A; Biller BMK; Tritos NA
    Clin Endocrinol (Oxf); 2018 Sep; 89(3):336-345. PubMed ID: 29873834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
    Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
    Danet-Lamasou M; Asselineau J; Perez P; Vivot A; Nunes ML; Loiseau H; San-Galli F; Cherifi-Gatta B; Corcuff JB; Tabarin A
    Clin Endocrinol (Oxf); 2015 Feb; 82(2):260-6. PubMed ID: 24975391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease.
    Trementino L; Cardinaletti M; Concettoni C; Marcelli G; Polenta B; Spinello M; Boscaro M; Arnaldi G
    Pituitary; 2015 Feb; 18(1):60-7. PubMed ID: 24482099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.
    Findling JW; Fleseriu M; Newell-Price J; Petersenn S; Pivonello R; Kandra A; Pedroncelli AM; Biller BM
    Endocrine; 2016 Nov; 54(2):516-523. PubMed ID: 27209465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
    Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
    Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay for Cushing's disease in an obese population.
    Aberle J; Schulze Zur Wiesch C; Flitsch J; Veigel J; Schön G; Jung R; Reining F; Lautenbach A; Rotermund R; Riedel N
    J Endocrinol Invest; 2018 Nov; 41(11):1325-1331. PubMed ID: 29550934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
    Carroll TB; Javorsky BR; Findling JW
    Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease.
    Newell-Price J; Pivonello R; Tabarin A; Fleseriu M; Witek P; Gadelha MR; Petersenn S; Tauchmanova L; Ravichandran S; Gupta P; Lacroix A; Biller BMK
    Eur J Endocrinol; 2020 Feb; 182(2):207-217. PubMed ID: 31804965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.
    Mallari RJ; Thakur JD; Barkhoudarian G; Eisenberg A; Rodriguez A; Rettinger S; Cohan P; Nieman L; Kelly DF
    J Clin Endocrinol Metab; 2022 Jan; 107(1):205-218. PubMed ID: 34478542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
    Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
    Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.
    Doi SA; Clark J; Russell AW
    Endocrine; 2013 Apr; 43(2):327-33. PubMed ID: 23238876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing's syndrome).
    Raff H
    Pituitary; 2022 Oct; 25(5):698-700. PubMed ID: 35334030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
    Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
    Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late-night salivary cortisol as a screening test for Cushing's syndrome.
    Raff H; Raff JL; Findling JW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome.
    Kuzu I; Zuhur SS; Demir N; Aktas G; Yener Ozturk F; Altuntas Y
    Endokrynol Pol; 2016; 67(5):487-492. PubMed ID: 26884297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?
    Barbot M; Albiger N; Ceccato F; Zilio M; Frigo AC; Denaro L; Mantero F; Scaroni C
    Pituitary; 2014 Apr; 17(2):109-17. PubMed ID: 23468128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease.
    Carrasco CA; Coste J; Guignat L; Groussin L; Dugué MA; Gaillard S; Bertagna X; Bertherat J
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4728-34. PubMed ID: 18728161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.
    Ceccato F; Marcelli G; Martino M; Concettoni C; Brugia M; Trementino L; Michetti G; Arnaldi G
    J Endocrinol Invest; 2019 Mar; 42(3):327-335. PubMed ID: 29987756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.